Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9CYP

Crystal structure of I19V mutant human PTP1B (PTPN1) at room temperature (298 K)

9CYP の概要
エントリーDOI10.2210/pdb9cyp/pdb
分子名称Tyrosine-protein phosphatase non-receptor type 1, MAGNESIUM ION (3 entities in total)
機能のキーワードptp1b, phosphatase, allostery, ptp, hydrolase
由来する生物種Homo sapiens (human)
タンパク質・核酸の鎖数1
化学式量合計37452.04
構造登録者
主引用文献Perdikari, A.,Woods, V.A.,Ebrahim, A.,Lawler, K.,Bounds, R.,Shah, D.S.,Singh, N.I.,Mehlman, T.S.,Riley, B.T.,Sharma, S.,Morris, J.W.,Keogh, J.M.,Henning, E.,Smith, M.,Farooqi, I.S.,Keedy, D.A.
Structures of human protein tyrosine phosphatase variants reveal targetable allosteric sites.
J.Biol.Chem., 301:110852-110852, 2025
Cited by
PubMed Abstract: Protein tyrosine phosphatase 1B (PTP1B) is a negative regulator of leptin signaling whose disruption protects against diet-induced obesity in mice. We investigated whether structural characterization of human PTP1B variant proteins might reveal allosteric sites to target for weight loss therapy. To do so, we selected 12 rare variants for functional characterization from exomes from 997 people with persistent thinness and 200,000 people from the UK Biobank. Seven of 12 variants impaired PTP1B function by increasing leptin-stimulated signal transducer and activator of transcription 3 phosphorylation in human cells. Focusing on the variants in and near the ordered catalytic domain, we ascribed structural mechanisms to their functional effects using in vitro enzyme activity assays, room-temperature X-ray crystallography, and local hydrogen-deuterium exchange mass spectrometry. By combining these complementary structural biology experiments for multiple variants, we characterize an inherent allosteric network in PTP1B that differs from previously reported allosteric inhibitor-driven mechanisms mediated by catalytic loop motions. The most functionally impactful variant sites map to highly ligandable surface sites, suggesting untapped opportunities for allosteric drug design. Overall, these studies can inform the targeted design of allosteric PTP1B inhibitors for the treatment of obesity.
PubMed: 41135676
DOI: 10.1016/j.jbc.2025.110852
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.99 Å)
構造検証レポート
Validation report summary of 9cyp
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon